Northern Trust
NRXS icon

Northern Trust’s Neuraxis NRXS Stock Holding History

Northern Trust’s Portfolio NRXS Stock Details NRXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$135K Sell
18,283
-2,463
-12% -$13.5K ﹤0.01% 4040
2025
Q4 		$94.2K Buy
+20,746
New +$62K ﹤0.01% 4150

Other funds holding NRXS

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return
PC
Panoramic Capital Larkspur, California $142M AUM 161.26% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust's NRXS Position: Q1 2026 in Review

Northern Trust reduced its Neuraxis (NRXS) stake by 12% in Q1 2026, selling an estimated $13.5K and leaving 18,283 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #4040.

Northern Trust first reported a position in NRXS in Q4 2025 and has held it in 2 quarters since. 26 funds tracked by Wall St. Rank hold NRXS as of Q1 2026.

  • Northern Trust held 18,283 shares of Neuraxis worth $135K as of Q1 2026.
  • Northern Trust sold 2,463 Neuraxis shares in Q1 2026, an estimated $13.5K.
  • Neuraxis made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4040 holding.
  • Northern Trust first reported a position in Neuraxis in Q4 2025 and has held it in 2 quarters since.
  • 26 funds tracked by Wall St. Rank held Neuraxis as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.